Drreddys Laboratories | RDY - Assets


Drreddys Laboratories reported INR6.26B in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
ANI Pharmaceuticals USD 1.42B 18.41M Mar/2026
Aurora Cannabis CAD 775.29M 18.43M Dec/2025
Bayer EUR 107.94B 3.4B Mar/2026
Canopy Growth CAD 1.11B 36.35M Dec/2025
Cipla INR 401.64B 27.77B Sep/2025
Corcept Therapeutics USD 814.88M 21.77M Mar/2026
Drreddys Laboratories INR 6.26B 161.9M Dec/2025
GlaxoSmithKline GBP 62.87B 1.75B Mar/2026
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Lonza CHF 18.97B 164M Dec/2025
Novartis USD 118.53B 7.58B Mar/2026
Pacira USD 1.21B 56.38M Mar/2026
Phibro Animal Health USD 1.45B 39.56M Mar/2026
Prestige Brands USD 3.49B 430K Mar/2026
Richter Gedeon HUF 1.68T 39.69B Dec/2025
Sun Pharmaceuticals INR 1.04T 116.06B Sep/2025
Supernus Pharmaceuticals USD 1.5B 48.08M Mar/2026
Teva Pharmaceutical Industries USD 40.04B 708M Mar/2026